The impact of anti-tumour necrosis factor therapy for rheumatoid arthritis on the use of other drugs and hospital resources in a pragmatic setting.

MLA

Sandhu, R. S., et al. “The Impact of Anti-Tumour Necrosis Factor Therapy for Rheumatoid Arthritis on the Use of Other Drugs and Hospital Resources in a Pragmatic Setting.” Musculoskeletal Care, vol. 4, no. 4, Dec. 2006, pp. 204–22. EBSCOhost, https://doi.org/10.1002/msc.92.

APA

Sandhu, R. S., Treharne, G. J., Douglas, K. M. J., Cassim, K., Saratzis, A., Piper, H., Erb, N., Jenkins, D., Tavakoli, M., Deighton, C., & Kitas, G. D. (2006). The impact of anti-tumour necrosis factor therapy for rheumatoid arthritis on the use of other drugs and hospital resources in a pragmatic setting. Musculoskeletal Care, 4(4), 204–222. https://doi.org/10.1002/msc.92

Chicago

Sandhu, R S, G J Treharne, K M J Douglas, K Cassim, A Saratzis, H Piper, N Erb, et al. 2006. “The Impact of Anti-Tumour Necrosis Factor Therapy for Rheumatoid Arthritis on the Use of Other Drugs and Hospital Resources in a Pragmatic Setting.” Musculoskeletal Care 4 (4): 204–22. doi:10.1002/msc.92.